Namraj Goire1,2, Ratan Kundu3, Ella Trembizki4, Cameron Buckley4, Tiffany R Hogan3, David A Lewis5,6, James M Branley2, David M Whiley4,7, Monica M Lahra3,8. 1. WHO Collaborating Centre for Sexually Transmitted Diseases, Sydney, Department of Microbiology, South Eastern Area Laboratory Services, Prince of Wales Hospital, Randwick, New South Wales 2031, Australia namraj.goire@uqconnect.edu.au. 2. Sydney Medical School Nepean, The University of Sydney, Nepean Hospital, Penrith, New South Wales 2747, Australia. 3. WHO Collaborating Centre for Sexually Transmitted Diseases, Sydney, Department of Microbiology, South Eastern Area Laboratory Services, Prince of Wales Hospital, Randwick, New South Wales 2031, Australia. 4. The University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital Campus, Herston, Queensland 4029, Australia. 5. Western Sydney Sexual Health Centre, Parramatta, New South Wales 2150, Australia. 6. Marie Bashir Institute for Infectious Diseases and Biosecurity & Sydney Medical School-Westmead, University of Sydney, New South Wales 2006, Australia. 7. Pathology Queensland Central Laboratory, Brisbane, Queensland 4029, Australia. 8. School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Kensington, New South Wales 2033, Australia.
Abstract
OBJECTIVES: Previous studies have shown that mixed-strain gonococcal infections can occur. However, it remains unclear whether such infections impact upon the reliability of Neisseria gonorrhoeae antimicrobial resistance (AMR) surveillance. In this study, we aimed to resolve this question by intensively sampling isolates from gonorrhoea-positive specimens in a high-risk population in Sydney, Australia. METHODS: A total of 615 N. gonorrhoeae isolates, originating from 63 clinical samples (31 rectal swabs and 32 throat swabs), were characterized. All isolates were subject to N. gonorrhoeae identification, antimicrobial susceptibility testing and genotyping by SNP-based MLST. RESULTS: Only 2 of the 63 (3.2%) samples provided evidence of mixed-strain infections. These comprised two rectal swabs that harboured isolates of different SNP-based MLST genotypes; however, the AMR susceptibility profiles of the different genotypes from these samples were indistinguishable. Within-sample differences in the AMR susceptibility profiles were observed for a further seven samples; however, the differences were not considered significant; MIC values were typically within a 2-fold difference or were close to test breakpoints. CONCLUSIONS: Results of this study provide further evidence that mixed-strain gonococcal infections do occur, although at low prevalence. Our data indicate that at a population level such infections are unlikely to impact significantly upon N. gonorrhoeae AMR surveillance.
OBJECTIVES: Previous studies have shown that mixed-strain gonococcal infections can occur. However, it remains unclear whether such infections impact upon the reliability of Neisseria gonorrhoeae antimicrobial resistance (AMR) surveillance. In this study, we aimed to resolve this question by intensively sampling isolates from gonorrhoea-positive specimens in a high-risk population in Sydney, Australia. METHODS: A total of 615 N. gonorrhoeae isolates, originating from 63 clinical samples (31 rectal swabs and 32 throat swabs), were characterized. All isolates were subject to N. gonorrhoeae identification, antimicrobial susceptibility testing and genotyping by SNP-based MLST. RESULTS: Only 2 of the 63 (3.2%) samples provided evidence of mixed-strain infections. These comprised two rectal swabs that harboured isolates of different SNP-based MLST genotypes; however, the AMR susceptibility profiles of the different genotypes from these samples were indistinguishable. Within-sample differences in the AMR susceptibility profiles were observed for a further seven samples; however, the differences were not considered significant; MIC values were typically within a 2-fold difference or were close to test breakpoints. CONCLUSIONS: Results of this study provide further evidence that mixed-strain gonococcal infections do occur, although at low prevalence. Our data indicate that at a population level such infections are unlikely to impact significantly upon N. gonorrhoeae AMR surveillance.
Authors: Jesse C Thomas; Sandra Seby; A Jeanine Abrams; Jack Cartee; Sean Lucking; Eshaw Vidyaprakash; Matthew Schmerer; Cau D Pham; Jaeyoung Hong; Elizabeth Torrone; Sancta St Cyr; William M Shafer; Kyle Bernstein; Ellen N Kersh; Kim M Gernert Journal: J Infect Dis Date: 2019-06-19 Impact factor: 5.226
Authors: Jolinda de Korne-Elenbaas; Arno Pol; Jacqueline Vet; Mirjam Dierdorp; Alje P van Dam; Sylvia M Bruisten Journal: Sex Transm Dis Date: 2020-04 Impact factor: 2.830
Authors: Qibin Duan; Chris Carmody; Basil Donovan; Rebecca J Guy; Ben B Hui; John M Kaldor; Monica M Lahra; Matthew G Law; David A Lewis; Michael Maley; Skye McGregor; Anna McNulty; Christine Selvey; David J Templeton; David M Whiley; David G Regan; James G Wood Journal: PLoS Comput Biol Date: 2021-11-04 Impact factor: 4.475